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Abstract 
Diabetes and depression are prevalent diseases that cause morbidity and mortality. Diabetes is a 
heterogeneous metabolic disease in which hypoglycemia is a central feature. Depression is 
associated with abnormalities in metabolically significant biological pathways, increased 
counter-regulatory, hormone release, and alteration in glucose transport function. Depression 
occurs in some individuals with diabetes and is associated with poor metabolic control, 
inadequate control of diet, and poor adherence to medication that can decrease quality of life. 
The prevalence of depression in Type 2 diabetes mellitus patients is significantly higher in the 
over 55 year old population than in the general public. The purpose of this quality improvement 
project was to assess whether a medication compliance program would improve the quality of 
life of older adults diagnosed with depression and diabetes. Orem’s self-care deficit theory 
provided a theoretical framework to guide and assist the patient with depression and diabetes to 
meet self-management regimen. The project question investigated whether compliance education 
program could improve the quality of life of adults with depression and diabetes.  A convenience 
sample of 28 patients diagnosed with depression and diabetes participated in the program with 
pre- and post data collection. Outcome data were collected pre and post intervention via the 
World Health Organization’s Quality of Life Questionnaire and calculated using percentage 
difference, revealing an improvement in quality of life. There were compelling improvements in 
physical health (+28.5%), social relationships (+32.3%), and environment (+25%). Measurable 
improvements were also seen in physical health (+15.1) and in general health (+3.6). These 
findings may serve to influence practice and can lead to positive social change in this population 
by decreasing the risk of complications and improve the well-being of these dual diagnosis 
patients.  
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Section 1: Overview of the Evidence-Based Project 
Introduction 
The worldwide burden of diabetes is projected to be 5.4% of the adult population 
by the year 2025 (Hayek et al., 2013). Quality-of-life (QOL) refers to the ways in which 
health, illness, and medical treatment influence an individual’s perception of functioning 
and well-being (Eren, Erdi, &Sahin, 2007). Diabetes mellitus (DM) is a chronic medical 
illness that places serious constraints on the life of the patient (Eren et al., 2007).  
Diabetes is a prevalent disease that causes significant morbidity and mortality and is 
associated with substantial health care cost in the United States (Edge, Zheng, &Simpson, 
2002). The disease is associated with multiple medical complications that decrease health 
related QOL and contributes to early mortality (Hayek et al., 2013). Depression is equally 
prevalent in the United States. It is estimated that approximately 3% of men and 5-9% of 
women have clinical depression (Edge, Zheng, & Simpson, 2002). The prevalence of 
depression in Type II DM patients is two to three times more in diabetic patients 
compared to the general population (Eren et al., 2007; Zagarins, Allen, Garb, & Welch, 
2012).According to Eren et al. (2007), DM is related to a significant deterioration in 
patients’ QOL and depression is often accompanied by marked reductions in QOL. 
Background 
Depression is a significant problem among patients with diabetes, with an 
estimated prevalence of 15-20% compared with 2-9% of the population not suffering 
from depression in the United States(Gonzalez et al., 2007). Depression is a devastating 
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disease that adversely affects all aspects of one’s existence. It is a pervasive disorder that 
afflicts individuals of all ages, cultures, and races. Nearly 340 million people worldwide, 
including 18 million in the United States, suffer from depression (Williams, Clouse, 
&Lustman, 2006). Given the high prevalence of depression in diabetes patients, 
understanding the relative importance of depression and diabetes-specific emotional 
distress on glycemic control is critical for formulating effective strategies to decrease 
diabetes-related morbidity and mortality (Zagarins et al., 2012).  The increased 
prevalence of depression in diabetic patients shows that depression has a negative 
influence on QOL (Eren et al., 2007). 
Project Question 
DM is chronic medical illness that places serious constraints on the life of patients 
(Eren et al., 2007). The prevalence of depression in DM patients is greater when 
compared to the general population (Eren et al., 2007). Therefore, the project question is: 
Does medication compliance education improve QOL scores as measured by pre and post 
World Health Organization’s Quality of Life Questionnaire (WHOQOL-BREF 
questionnaires in older adults with dual diagnosis of depression and diabetes? Educating 
and supporting patients in managing their daily life with depression and DM is an 
important goal. Thakurdesai, Kole, and Pareek (2004) believed that educating patients 
about their health will lead to a better adherence to treatment and will improve their 
health outcome. 
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Purpose Statement 
This project’s focus is on patients with a preexisting diagnoses of both diabetes 
and depression. The purpose of this quality improvement project was to assess whether 
medication compliance education improved the QOL in older diabetic patients with 
depression. The aim of this project was to improve the QOL of adults with depression 
and diabetes through medication compliance education. 
Problem Statement 
Depression has been associated with severe diabetes-related outcomes including 
poorer glycemic control, cardiovascular disease risk factors, a greater diabetes symptom 
burden, and poorer quality of life (Waitzfelder et al., 2010). DM is a chronic disease that 
causes serious health complications, such as heart disease, renal failure, and stroke 
(Kilbourne et al., 2005). Depression has an adverse impact on medication adherence and 
subsequent health outcomes among older, chronically ill adults (Kilbourne et al., 2005). 
Depressive symptoms are linked to inadequate treatment adherence of several chronic 
diseases, including DM, coronary artery disease, asthma, and hypertension (Kilbourne et 
al., 2005). Older patients may be especially at risk for the adverse consequences of poor 
medication adherence, in part because of multiple medication use, coexisting chronic 
conditions, and functional decline (Kilbourne et al., 2005). 
Psychiatric disorders are known to deteriorate the control of chronic diseases such 
as DM (Cezaretto, Siqueira-Catania, Risso de Barros, Salvator, & Ferreira, 2012). 
Benefits induced by behavioral interventions on lifestyle have shown to be more 
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pronounced than pharmacological interventions (Cezaretto et al., 2012). Changing 
behavior may be aggravated by the presence of psychiatric disorders, which have been 
associated with decreased adherence to treatments (Cezaretto et al., 2012). If medication 
education for the diabetic patient with depression improves self-care behaviors, it may 
also positively affect other chronic medical illnesses with important self-care components 
(Williams, Clouse, &Lustman, 2004). One of the most important targets in the 
management of patients with diabetes is to control blood glucose levels by proper 
treatment, including adherence to prescribed treatment (Al-Qazar et al., 2011).  
Management of DM is a lifelong process that requires continuous efforts, both 
from the primary care providersand the patients. Patients need to follow their medication 
and meal plans, adjust their physical activity, lose weight if they are obese, and monitor 
their blood glucose (Al-Qazar et al., 2011). Williams et al. (2004) hypothesized that a 
collaborative care intervention may improve functional status, self-care behaviors, and 
glycemic control. This quality improvement project evaluated whether medication 
education improves QOL in patients diagnosed with diabetes and depression. 
Significance/Relevance to Practice 
According to Hodges and Videto (2011), a comprehensive needs assessment 
begins by looking at a group’s QOL. Kettner, Moroney, and Martin (2013) stated that in 
determining if individuals have a need, it is important to evaluate existing conditions 
against some socially established standards. They further stated that Maslow (1954) 
argued that people become aware of their needs in a specific manner, by satisfying the 
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lower needs before the higher ones(as cited in Kettner et al., 2013).Until physiological 
survival needs are met (e.g., food and shelter), a person cannot be overly concerned with 
safety and security (Kettner et al., 2013). Achievement of this second level of need then 
allows attention to higher levels – the need for love and self-actualization (Kettner et al., 
2013). According to Ventegodt, Merrick,and Andersen(2003), Maslow’s philosophy 
concerning consciousness, existentialistic choices, personal growth, and self-actualization 
points to another way of helping patients.  By supporting patients to assume 
responsibility for their existence and needs, they can improve their own QOL, health, and 
general ability to function (Ventegodt et al., 2003). 
Education of diabetic patients has been shown to have a beneficial effect on 
general well-being, reducing negative well-being (depression), and improving positive 
well-being of the patients (Tankova, Dakovska, &Koev, 2004). It is well known that 
depression is about two to three times higher among people with diabetes compared with 
the general population. Tankova et al.(2004) asserted that education should be an integral 
part of diabetes care, with it having been shown to be beneficial not only on glycemic 
control, but also on the psychological well-being of patients. 
Depression, when occurring in those suffering from diabetes, has consistently 
been associated with poor metabolic control (factors such as increased weight, high blood 
pressure, and high blood sugar and lipid levels), which leads to more complications of the 
disease (Chou, Ho,& Chi, 2005). Medication compliance education can have a positive 
effect on addressing the skills for self-management of the disease and reinforcing 
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patients’ need for adherence to treatment, thereby potentially improving overall health 
status (Lal et al., 2011). 
Evidence-Based Significance of the Project 
The value that this project offers to practice is that it provides information to 
patients and strengthens their knowledge base which could improve their self-care 
management. According to Bradshaw (2010), evidence-based practice (EBP) informs 
caring and clinical practices with the best available knowledge, validating nursing as a 
profession grounded in science. During the past 10 years, EBP has become the dominant 
theme of practice, education, and policy in health care (Bradshaw, 2010). Professional 
guidelines on diabetes care all call for self-management education that facilitates 
effective self-care and positive behavior change for people with diabetes (Lipman & 
Sherr, 2013). The combination of diabetes and depression may account for at least some 
people’s seeming inability to effectively self-manage their diabetes and achieve optimal 
outcomes (Lipman&Sherr, 2013).This project supports the Healthy People 2020 goals: to 
create social and physical environments that promote good health and QOL, healthy 
development, and healthy behaviors (U.S. Department of Health & Human Services, 
2010). 2012). The potential for improving life really lies in helping the patient to 
acknowledge their own lust for life and the fulfillment of their needs (Ventegodt, 
Merrick,& Andersen,2003). According to Surucu and Turkey (2012), patients with 
diabetes must learn to evaluate themselves and decide what action is needed to attend to 
their needs. 
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Educating and supporting patients in managing their daily lives with a chronic 
disease like diabetes is an important goal of therapy (Thakurdesai, Kole, &Pareek, 
2004).Therefore, this project is significant to practice through patient education, which 
focused on lifestyle modification, daily weight management, diet, and medication 
compliance to improve the QOL of adults diagnosed with depression and diabetes. 
Implications for Social Change in Practice 
 The concept of empowerment is of increasing interest. Empowerment is 
associated with control, and without control there is a feeling of powerlessness (Lord & 
Hutchison, 1993). A growing number of people are searching to understand the meaning 
of empowerment and ways it can be used to change their lives (Lord & Hutchison, 1993). 
At the individual level, powerlessness can be seen as the expectation of the person that 
their own actions will be ineffective in influencing the outcome of life events (Lord & 
Hutchison, 1993). 
 According to Lord and Hutchison (1993), empowerment is understood as a 
process for people to take power, and in order to do so they need to gain information 
about themselves and their environment and be willing to identify and work with others 
for change. Education is an integral part of managing chronic diseases like depression 
and diabetes. Depression and diabetes not only have a negative effect on the QOL of 
patients, but also on their adherence to treatment, which prevents them from making 
change in their lives.  
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Definition of Terms 
Chronic illnesses: Diseases that do not resolve spontaneously, but are often 
resolved or prevented by lifestyle changes. Chronic illnesses are responsible for an 
estimated 80% of the global disease burden worldwide (Nieman& Cheng, 2011). 
Compliance or adherence: The extent to which a person’s behavior coincides 
with medical or healthcare advice. Assessing compliance is important for both research 
and patient care purposes. Poor compliance leads to suboptimal treatment of medical 
conditions and may lead to adverse health outcomes (Lal et al., 2011). 
Depression: A range of mental problems characterized by loss of interest and 
enjoyment in ordinary experiences, as well as low mood and associated emotional, 
cognitive, physical, and behavioral symptoms (Penninx, Milaneschi, Lamers, 
&Vogelzangs, 2013). 
Diabetes mellitus: A group of metabolic diseases characterized by abnormally 
high blood glucose levels. Individuals with uncontrolled diabetes are at risk for 
developing serious health complications. Type 2 diabetes, in particular, occurs when the 
pancreas creates insufficient amounts of insulin or when the body becomes unable to use 
the limited supply of insulin effectively (Fortmann, Gallo, Walker, &Phillis-Tsimikas, 
2010). 
Empowerment: A process whereby patients have the knowledge, skills, attitudes, 
and self-awareness necessary to influence their own behavior and that of others in order 
to improve the quality of their lives (Assimakopoulou, 2007). 
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Hemoglobin A1C:A time averaged blood glucose level during the previous 2 to 
3months. This amount is used as a gold standard for long-term follow-up of glycemic 
control (Hanas& John, 2013). 
Needs assessment: Conducted to identify gaps that lead to the development of 
programs. The assessments are usually done before starting a new endeavor as a critical 
step for planning and program implementation. A carefully completed needs assessment 
will specify outcomes, variables, and key process points to be evaluated in the strategies 
to alleviate discrepancies (Hung &Altschuld, 2013). 
Qualityoflife: The ways in which health, illness, and medical treatment influence 
an individual’s perception of functioning and wellbeing (Eren et al., 2008). The World 
Health Organization Quality-of-Life –Bref (WHOQOL)has 26 items that are derived 
from WHOQOL-100, which is a multilingual, multicultural, generic quality of life 
instrument, developed across 15 field centers (Aigner et al, 2006). The instrument has 
four domains related to quality of life: physical health, psychological health, social 
relationships, and environment (Aigner et al., 2006). 
Self-care: Engaging in behaviors that promote health and limit illness. Self-care 
maintenance refers to behaviors such as medication adherence and symptoms monitoring 
that are used to maintain physical stability (Tung et al., 2013). Self-care management 
refers to how patients respond to symptoms of their disease (Tung et al., 2013). 
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Self-efficacy: Concepts related to the beliefs about one’s own capabilities to 
produce designated levels of performance that exercise influence over events that affect 
one’s life (Sharoni& Wu, 2012). 
Self-management: Extends beyond the patient merely following instructions; it 
entails teaching the patients to monitor their symptoms, make decisions, and evaluate the 
impact of such decisions. Self-management is viewed as a cognitive decision making 
response to symptoms and is conceptualized as a process with stages from novice to 
expert (Evangelista &Shinnick, 2008). 
Assumptions 
An assumption of this project was that the information from the mental health 
clinic database was current and that the participants were able to read and understand 
English, as the questionnaires were in English. It was also assumed that the participants 
were honest when answering the questionnaires. Another assumption I held during this 
project was that the participants would have a desire to improve their QOL. It was also 
assumed that the program’s educational intervention would serve to improve participants’ 
knowledge of how to take their medications to control symptoms. 
Limitations 
A major limitation of this project was that the population was from a single clinic, 
and there was no control group to limit the internal validity of the outcome. A second 
limitation was that the size of the sample was small, and therefore, the results may not 
generalize to the larger population. Thirdly, the cultural and language differences of the 
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participants may have influenced the results. Compliance to treatment can be problematic 
to measure with self-report questionnaires since some participants may have found it 
difficult to disclose their personal information. The potential for response bias may be 
attributed to the self-reporting nature of the data. There was always a risk that the patients 
overestimated their compliance. 
Summary 
Depression is associated with lower QOL, non-adherence to medical regimen, 
decrease in self-care behaviors, diabetic complications, and higher costs and healthcare 
utilization (Lamerr, Jonkers, Bosma, Knottnerus, & van Eijl, 2010). Furthermore, 
depression has a negative impact on physical activity, is associated with persistently 
higher hemoglobin A1c levels over time, and may reduce glycemic control through 
central nervous system regulatory changes (Lamerr et al., 2010).A person with diabetes 
must learn how to evaluate themselves, decide what actions need to be taken, and 
perform these actions. Diabetes self-management education is the process of informing, 
strengthening, and empowering the diabetes patient for diabetes self-care (Suruco& 
Turkey, 2012). QOL has become an important outcome in healthcare, especially for 
assessing treatment outcome, and it has become an important outcome criterion for 
psychiatric interventions in general (Aigner et al., 2006). 
Diabetes self-management continues to receive a lot of attention, both from 
researchers wishing to study ways of enhancing management and from clinicians who 
deal with the practical aspects of their patients’ self-care efforts each day. Many studies 
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have indicated that education programs for patients with DM have produced significant 
benefits in glycemic control (Hayek et al., 2013). The addition of depression to diabetes 
has a severe impact on QOLas depression in the diabetic patient may affect the capacity 
to maintain medication vigilanceandmaintain good diet and other lifestyle factors 
(Goldney, Fisher, Phillips, & Wilson, 2004). 
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Section 2: Review of Scholarly Evidence 
Introduction 
 The worldwide burden of diabetes is increasing and is projected to be 5.4% of the 
adult population by the year 2025 (Rasekaba et al., 2012). The United States population 
models predict that the prevalence of diabetes in adults will increase from 14% in 2010 to 
at least 21%by 2050 (Rasekaba et al., 2012). According to the World Health Organization 
(WHO), major depressive disorder is the leading cause of years lost to disability, and 
evidence consistently shows depressive disorder significantly impairs QOL (Vilhauer et 
al., 2013). The WHO defines QOL as an individual’s perception of their position in life in 
the context of the culture and value systems in which they live and in relation to their 
goals, expectations, standards, and concerns (Vilhauer et al., 2013). 
Depression has a major impact on the functioning of patients both mentally and 
physically (van den Akker, Schuurman, Metsemakers, &Buntinx, 2004). The co-
occurrence of depression and other chronic medical conditions has been shown to 
increase functional impairment and to decrease the QOL (van den Akker et al., 2004). 
Diabetes and depression share common patho-physiological mechanisms, and depression 
leads to poorer outcomes and increased risk of complications as a result of peripheral 
glucose deregulation (Lee et al., 2009). The relationship between poorer QOL and greater 
depression is stronger in patients with poorer glycemic control than those with better 
control in individuals with Type II diabetes (Lee et al., 2009). Understanding which 
dimensions of QOL are associated with the co-morbidities of depression and diabetes is 
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important for day to day clinical management of this 2004).This review will discuss the 
etiology of both depression and diabetes, and studies that focused on teaching the 
participants how to formulate new ways of thinking about their diagnosis and the effect 
on their QOL, offering specific skills for setting goals, and making problem solving 
decisions. 
Literature Review Strategy 
The literature search was conducted to analyze and summarize the information 
that exists with regard to depression and diabetes and the effect of education on QOL. 
The search was completed using CINAHL and MEDLINE simultaneously and applying 
Boolean string searches. Other databases used in the research were Pro-Quest and Sage 
Full-Text. Burns and Grove (2009) stated that the Boolean operators are the three words: 
AND, OR, and NOT. The Boolean operators AND and NOT are used with identified 
concepts. The following key words were also used: quality-of-life, depression, diabetes, 
medication compliance, and education. The Boolean string operator AND was used when 
searching for the presence of two or more terms in the same citation. Only peer-reviewed 
articles were included and the literature search was based on relevancy to the DNP 
project. In searching the literature for diabetes and depression, 11,277,312 articles 
appeared, 330 were reviewed, and 52 were selected. In the search for diabetes and 
depression and adherence to medication education, 2,284,594 articles appeared, 234 
reviewed, and 12 were selected. In the search for diabetes, depression and 
QOL,3,594,618 articles appeared, 145 were reviewed,and13were selected. In the search 
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for reliability and validity, five articles were reviewed and two were used. The total 
amount of literature used for this project was79 articles. 
Specific Literature 
There is an increasing recognition that the impact of chronic illnesses and their 
treatments must be assessed in terms of their influences on QOL in addition to more 
traditional measures of medical outcomes, such as morbidity and mortality (Jacobson, 
Samson, & Groot, 1994). Type I and Type II diabetes are typical of chronic illnesses that 
can influence QOL because the treatments are burdensome and the complications can be 
debilitating and life threatening (Jacobson et al., 1994). DMis a chronic disease that 
causes serious health complications, such as heart disease, renal failure, and stroke. 
According to Surucu and Turkey (2012), uncontrolled blood glucose level is the basic 
problem in individuals with diabetes. Elevated blood glucose level leads to 
cardiovascular diseases, nephropathy, neuropathy, lower extremity diseases, amputations, 
and visual impairment(CITE).  
Depression and DM may result from a common biological vulnerability or from 
common environmental risk factors (van den Akker, Schuurman, &Buntinx, 2004). 
Depression may increase the risk for DM through increased sympatho-adrenal system 
activity or a dysregulation of the hypothalamo-pituitary adrenal axis (van den Akker et 
al., 2004). Depression is estimated to be the second leading cause of burden of disease 
worldwide (Lamers et al., 2011). According to the WHO, depression is responsible for 
the greatest proportion of burden associated with nonfatal health outcomes, accounting 
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for approximately 12% total years lived with disability (Egede& Ellis, 2010). Depression 
is associated with lower QOL and nonadherence to medical regimes and self-care 
behaviors (Lamers et al., 2011). 
According to Goldney, Phillips, Fisher, and Wilson (2004), a number of studies, 
including meta-analyses, have shown the association between diabetes and depression. 
This is an important public health issue because depressive disorders have generally been 
associated with the outcomes of chronic diseases like diabetes (Goldney et al., 2004). 
Empirical research has strongly suggested that depression is more prevalent among adults 
with diabetes than among the general population (Talbot &Nouwen, 2000). To date, the 
reasons for the higher prevalence rates of depression in diabetic patients are not yet fully 
understood (Talbot &Nouwen, 2000). The determination of the presence of a mood 
disorder caused by a medical condition is a complex issue, especially in the absence of 
specific markers for depression (Osborn et al., 2011). Individuals with diabetes and co 
morbid depression have been shown to have poor adherence to diabetes medications, 
poor adherence to dietary recommendations, poor glycemic control, and more related 
complications (Osborn et al., 2011). 
Increasing evidence has suggested that depression plays an important role in the 
development and worsening of diabetes (Sacco et al., 2005). In people with diabetes, 
depression is associated with higher blood sugar levels, poorer adherence to treatment, 
more medical complications, and higher hospitalization rates (Sacco et al., 2005). Along 
with medication adherence, the primary components of the diabetic regimen involve 
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modification in diet and increased exercise (Sacco et al., 2005). Symptoms of depression 
(e.g., fatigue, hopelessness) may interfere with adherence to these relatively demanding 
recommendations, culminating in adverse health outcomes (Sacco et al., 2005).Studies 
have shown that enhanced involvement of patients in treatment decision making is 
associated with higher patient satisfaction, improved adherence, and improved clinical 
outcomes (Loh et al., 2007). However, a depressed patient’s diminished ability to think, 
concentrate, or the indecisiveness associated with depression may impair the patient’s 
competence to participate in treatment decision making (Loh et al., 2007).  
The prevalence of clinical depression in diabetic patients is approximately twice 
that of the general population (Pibernik-Okanovic, Ajdukovic, Lovrencic, &Hermanns, 
2011). The data in the literature have consistently demonstrated a synergistic interaction 
between diabetes and depression that increases the risk for poor health outcomes 
(Pibernik-Okanovic et al., 2011). Compared to patients with diabetes alone, patients with 
depression and diabetes have poorer self-management (i.e., adherence to diet, exercise 
regimen, and blood glucose monitoring) and significantly more lapses in refilling oral 
hypoglycemic, lipid-lowering, and antihypertensive prescriptions (Pibernik-Okanovic et 
al., 2011). 
Depression, long recognized as a consequence of physical illness, is increasingly 
being perceived as a potential risk factor for compromised health, particularly among 
older adults (Black et al., 2003). A number of studies cited by Black et al. (2003) have 
shown that depression predicts the onset of many medical conditions, including 
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hypertension, heart disease, cancer, stroke, and angina, as well as Type 2 diabetes. Prior 
research has also shown depression as a predictor of mortality, as well as the onset of 
disability (Black et al., 2003). Despite this evidence, few studies have examined the 
influence of depression on the course of chronic disease, particularly with a large sample 
of older adults living in the community (Black et al., 2003). 
In earlier studies, Black(1998,1999) using the Hispanic Established Population for 
the Epidemiologic Study of the Elderly (EPESE) survey, demonstrated that depressive 
symptoms were associated with a number of poor health indicators among older diabetic 
Mexican Americans. These health indicators included elevated rates of co morbid 
medical conditions (Black et al., 2003). In the study, Black et al. (2003) used longitudinal 
data from the Hispanic EPESE survey to assess the separate and combined influences of 
depression and diabetes on the incidence of macro-vascular and micro-vascular 
complications, functional disability, and mortality among older Mexican Americans. This 
was a particularly appropriate population for the examination of this relationship because 
older Mexican Americans experience elevated rates of both diabetes and depression as 
25-30% of Mexican Americans aged >65 years have Type 2 diabetes and as many as 
25% of these individuals report significant levels of depression (Black et al., 2003). 
DM is a heterogeneous metabolic disease in which hyperglycemia is a central 
feature (Musselman, Betan, Larsen, & Phillips, 2003). The associated abnormalities in 
protein, carbohydrate, and fat metabolism are the result of insufficient insulin action on 
peripheral target tissues due to insufficient insulin secretion (Type I), diminished tissue 
19 
 
 
response to insulin (Type II), or some combination of both (Musselman, Betan, Larsen, & 
Phillips, 2003). Depression is associated with important patho-physiologic alterations that 
may contribute to the increase vulnerability of depressed patients to DM (Musselman et 
al., 2003). Although the underlying mechanisms are poorly understood, depression is 
associated with abnormalities in metabolically significant biologic pathways--increased 
counter-regulatory hormone release and action, alterations in glucose transport function, 
and increased immune-inflammatoryactivation (. Such abnormalities could contribute to 
insulin resistance and/or pancreatic B-islet cell dysfunction (Musselman et al., 2003). 
Understanding the bidirectional relationship between depression and diabetes, including 
the biological, psychological, and socio-cultural pathways of influence, is critical to the 
treatment and prevention of diabetes (Musselman et al., 2003).  
Self-management of chronic illnesses includes working together with healthcare 
providers, self-monitoring of blood glucose, implementing medication regimens, and 
following prescribed diet and exercise regimens (Eren, et al., 2006). In the Eren et al. 
(2006) study, the authors believed that diabetes can have considerable consequences on 
the quality of everyday life, with possible limitations in physical activity, social life, 
family relations, and leisure activities. According to Ciechanowski, Katon and 
Russo(2000),chronic illnesses have shown that depression has been associated with poor 
adherence to diet and exercise regimens in patients with diabetes. In Eren et al.’s study, 
there were negative correlations between HbA1c, an indicator of metabolic control, and 
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QOL scores. The significant overlap between depression and diabetes is also reflected by 
results from neuropsychological and neuro-imaging investigations (Rustad et al., 2011). 
Gonzalez et al. (2007) believed that major depression is a significant problem 
among patients with diabetes, with an estimated prevalence of 15-20%, compared with 2-
9% in the general population. The study by Gonzalez et al. contributed to the extant 
literature by challenging the categorical conceptualization of major depression as a risk 
factor for non-adherence to diabetes self-care. Other literature also has suggested that 
clinically significant levels of depression are associated with a range of poorer self-care 
behaviors, including adherence to diet, exercise, and prescribed medications (Gonzalez et 
al., 2007). 
DM is the fifth deadliest disease in the United States, and more than a million 
people develop the disease each year (Grandy, Chapman, & Fox, 2008). The primary risk 
factors for the development of Type 2 DM include overweight, sedentary lifestyle, age 
over 45 years, and/or family history (Grandy et al., 2008). African Americans, Latinos, 
and Native Americans are at increased risk, as are women who have had babies weighing 
more than nine pounds at birth (Grandy et al., 2008).Grandy et al. (2008) provided 
evidence of the impact on health-related QOL and depression in a large sample of Type II 
DM, high risk and low risk groups with a high survey response rate, representative of the 
U.S. population. 
The challenge of poor adherence to medication has been debated for at least 3 
decades. This problem has been generally ignored or not perceived as a serious public 
21 
 
 
health issue (Hayek et al., 2013). Patients’ lack of adherence to their medication regimen 
probably rests on the fact that they perceive their role in their care as largely passive 
(Hayek et al., 2013). 
The worldwide burden of diabetes is projected to be 5.4% of the adult population 
by the year 2025 (Hayek et al., 2013). The disease is associated with multiple medical 
complications that decrease health-related quality of life and contribute to early mortality 
(Hayek et al., 2013). It is well-established that DM requires continuous medical care, 
self-management by patients, education, and adherence to prescribed medication to 
reduce the risk of long term complications (Hayek et al., 2013).The mechanism by which 
behavioral adherence influences depression, remains unclear. Although the effects of 
physical activity on depression may be physiologically mediated, the influence of both 
diet and exercise adherence on depression can be more parsimoniously explained by 
cognitive processes (Sacco et al., 2005). Previous research has supported the association 
of anxiety/depression and hyperglycemia (Hayek et al., 2013). When these conditions 
coexist, the risk of developing comorbidities and complications increases, resulting in 
greater patient suffering and escalating costs (Hayek et al., 2013). Depressive symptoms 
markedly impair quality of life, especially for those with Type 2 diabetes (Hayek et al., 
2013). 
General Literature 
DM, one of the fastest growing chronic illnesses in the United States, refers to a 
group of metabolic diseases characterized by abnormally high blood glucose levels. In 
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2008, the Center for Disease Control and Prevention reported that 24 million people in 
the United States were diagnosed with diabetes and estimated that another 57 million 
people met criteria for prediabetes, a condition that puts people at risk for developing 
diabetes (as cited in Fortmann et al., 2010). Diabetes is a prevalent health condition that 
is associated with significant morbidity and mortality. An improvement in medication 
adherence may lead to better glycemic control, which, in turn, may reduce complications 
and healthcare utilization, such as the likelihood of hospitalization and emergency 
department visits. 
Depression is not a normal part of aging. However, depression is the most 
prevalent, yet least recognized and most untreated, psychiatric disorder among older 
adults (Karakus& Patton, 2011). The increased prevalence of depression in diabetes is 
explained partially by the fact that depression is an independent risk factor for 
development of type 2 diabetes (Williams, Clouse,&Lustman, 2006). 
According to Egede& Ellis (2010), reports from the International Diabetes 
Federation (IDF) have indicated that the prevalence of DM has reached epidemic levels 
globally. Estimates for 2010 indicate that 285 million adults have diabetes in the seven 
regions of the IDF(Egede& Ellis, 2010). It is also believed that by 2025, more than 75% 
of the world population with diabetes will reside in developing countries (Egede& Ellis, 
2010). The countries with the largest populations of adults with diabetes will include 
India, China, and the United States (Egede& Ellis, 2010).  
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Depression is another condition with high prevalence worldwide. Approximately 
349 million people worldwide suffer from depression at any given time, including 18 
million in the United States (Egede& Ellis, 2010). Osborn, Kozak, and Wagner (2010), 
stated that patients with comorbid depression develop decreased physical functioning and 
experience increased health care costs and higher rates of disabling and life-threatening 
complications. Osborn et al. believed that up to half of depressed patients in the general 
population are undiagnosed or undertreated, but the rates for patients with diabetes are 
lower (Osborn, Kozak& Wagner, 2010). 
Major depressive disorder is a leading cause of disability in the United States 
(Henke, Chou, Chanin, Zides, &Scholle, 2008). Nearly one in eight individuals have an 
episode of depression once in their lifetime, and 18.8 million adults suffer from a 
depressive illness each year (Henke et al., 2008). Henke et al. (2008) described several 
barriers to the care of depression, which included difficulty diagnosing depression, 
patient resistance, fragmented mental health system, insurance coverage, and lack of 
expertise. These barriers are largely consistent with previous empirical research 
identifying barriers through physician survey (Henke et al., 2008).Given the negative 
consequences associated with depression, addressing depressive symptoms in diabetic 
patients is of vital importance and may improve self-care behaviors and help the burden 
of diabetes-specific symptoms and emotional distress (Lamers et al., 2011). 
According to Egede and Ellis (2010), two major hypotheses currently exist to 
explain the casual pathway between diabetes and depression. One hypothesis asserts that 
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depression precedes Type 2diabetes. Unfortunately, the mechanisms underlying the 
association are not clearly understood. In theory, the increased risk of Type 2 diabetes in 
individuals with depression is believed to result from increased counter-regulatory 
hormone release and action, alteration in glucose transport function and increased 
immune-inflammatory activation (Egede& Ellis, 2010).  
The second hypothesis is that depression in patients with Type 1 and Type 2 
diabetes results from chronic psychosocial stressors of having a chronic medical 
condition(Egede& Ellis, 2010). This hypothesis is supported by at least two important 
studies. The first was a study of 8,870 participants from the National Health and Nutrition 
Examination Survey Epidemiologic Follow-up Survey, who were free of diabetes at 
baseline, were assessed for depression, and were followed for nine years (Egede& Ellis, 
2010). There was no evidence that depression was associated with an incident of 
diabetes; however, the study did show 3.7-fold increased odds of depression in those with 
a prior diagnosis of diabetes (Egede& Ellis, 2010). The National Institute of Health 
defined health disparities as the difference in the incidence, prevalence, morality, and 
burden of disease and other adverse health conditions that exist among specific 
population groups in the United States. The Hispanic population exhibits a higher 
prevalence of Type 2 diabetes, more frequent complications, greater disease severity, and 
worse outcomes than nonHispanic Caucasians (Fortmann et al., 2012). 
Black, Markides and Ray (2003) concluded that speculation regarding the 
pathways by which depression impacts diabetes falls into two broad categories: psycho-
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behavioral and patho-physiological. Depression may influence diabetes through 
decreased motivation to maintain behaviors that will protect against the development or 
worsening of diabetes, such as proper weight, diet, and exercise. Black et al. further 
stated that the study was unique in that it was the first large, population-based study to 
show that the interaction between depression and diabetes has a synergistic effect on 
mortality and the development of complications and disability (Black, Markides& 
Ray,2003). 
Rustad, Musselman, and Nemeroff (2011) concluded that diabetes and depression 
are conditions characterized by systemic inflammation, and both are considered risk 
factors for cardiovascular disease and mortality. The authors further stated that much of 
the current literature regarding the intertwined nature of diabetes and depression is cross-
sectional in nature. They therefore asserted that future research should focus on 
longitudinal, prospective studies to determine casual factors (Rustad et al., 2011). 
Depression adversely affects the course of coexisting medical illness, contributing 
to increased symptom burden, functional impairment, and mortality (Williams et al., 
2004). Depression first presents in medical settings, rather than mental health settings. 
Health care providers must be better prepared to manage depression in their diabetes 
patients (Osborn et al., 2010). Osborn et al. (2010) believed that gaps in the diagnosis of 
depression may be due to barriers on many levels, including, but not limited to, lack of 
clear depression treatment guidelines.  
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Compliance or adherence is defined as the extent to which patients take 
medications as prescribed by a health care provider and in accordance with instructions 
given (Cohen, Christensen,& Feldman, 2012; Lal et al., 2011). An accurate assessment of 
adherence is essential for effective treatment planning. Although there is no gold standard 
for measuring adherence, the use of a variety of methods has been reported in the 
literature (Meece, 2013). Other barriers include visit duration, reimbursement structures, 
and the availability of affordable mental health services (Osborn et al., 2010). Diabetic 
patients with comorbid depression develop decreased physical functioning, experience 
increased health care costs, and higher rates of disabling and life-threatening diabetes 
complications (Osborn, et al., 2010). Collaborative care and structured care, involving a 
greater role for non-medical specialists to augment primary care, has emerged as a 
potentially effective intervention to improve quality of care and patient outcomes in 
patients with depression and medical illnesses such as diabetes (Rustad et al., 2011). 
In diabetes, the incidence and severity of complications can be reduced through 
tight metabolic control, something that can be attained through strict patient self-
management and medication compliance (Huang et al., 2007). Assessment of compliance 
in diabetic care can be accomplished by having the patients monitor their blood glucose 
levels daily using a glucometer(Huang et al., 2007). To achieve good glycemic control 
and delay or prevent the disease related medical complications, diabetes self-care 
management should be adopted as the main modality of care; this includes adherence to 
diet and exercise, blood glucose monitoring, and compliance with medications. 
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Symptoms of depression can be measured by using a depression scale and managed with 
medications and referral to psychotherapy (Huang et al., 2007).  
Depressive symptoms in individuals with diabetes are related to worsening of 
diabetes self-management, poor functioning, and high HbgA1C (Huang et al., 2007). 
Therefore, medication education may help improve disease management and improve 
self-care behaviors, improving QOL. Williams, Clouse, and Lustman (2006) stated that 
the increased prevalence of depression in diabetes is explained partially by the fact that 
depression is an independent risk factor for development of Type 2 diabetes. Depression 
adversely affects a number of behaviors that could be relevant, including dietary 
behavior, tobacco use, and physical activity, cognitive functioning, and adherence to 
medical treatment (Williams et al., 2006). 
Apart from the considerable technological and scientific progress of the last 
decades in the field of DM, patient education is considered the most noticeable 
innovation in patient care (Tankova, Dakovska, &Koev, 2004). Numerous studies have 
demonstrated the beneficial effects of education in terms of glycemic control, decreased 
hospitalizations, and lower rates of acute complications (Tankova et al., 2004). Because 
the population is aging, most patients seeking care from primary care physicians will 
have more than one chronic illness. A coordinated therapeutic approach that considers 
coexisting chronic disease is essential to effective care (Lin et al., 2006). 
Patient education is accepted as an integral part of treatment and effective 
management of any chronic disease (Tankova et al., 2004). Strategies needed to 
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maximize the effectiveness of treatment for patients with Type 2DM include improving 
adherence to medication, physical activity, and nutrition (Meece, 2013). Programs 
designed to help communication among all health care providers, including doctors, 
diabetes educators, nurses, and pharmacists, can help to ensure that patients receive the 
best available collaborative care (Meece, 2013). 
In recent years there has been an attempt in nursing to provide care based on 
evidence-based research (Hashemi et al., 2013). Since the theories and models of nursing 
direct clinical, research and training activities in this field, the use of using models is one 
of the key steps to achieve this goal (Hashemi et al., 2013).  Orem’s Self Care Model is a 
suitable clinical guideline for planning and implementing the principles of self-care and is 
used as a conceptual framework to guide self-care programs (Hashemi et al., 2013). 
Theoretical Framework 
Because conceptual frameworks and models guide the plan and implementation of 
care in a purposeful way, Orem’s self-care deficit theory provides a theoretical 
framework to guide assistance of a client with diabetes to meet self-management 
requirements (Kumar, 2007). Through her experiences of nursing and education, 
Dorothea Orem developed a nursing model based on the concept of self-care deficit 
(Comley, 1994). Models such as Orem’s can be beneficial to the development of the DNP 
project because they assist with understanding the influences if health behaviors (Hodges 
&Videto, 2011). Zaccagniniand White (2011) stated that in order to understand her 
general theory, it is essential to grasp the following six concepts.  
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First, self-care is initiating and performing activities to maintain life, health, and 
well-being (Kumar, 2007). It is the patient’s continuous contribution to his/her own 
existence, once the education is given. In this concept, the patients will be able to perform 
the actions to regulate their health and functioning (Kumar, 2007). They should include 
daily exercise, should maintain self-monitoring of blood glucose, and should maintain a 
balance of diet and daily medication regimen.  
Secondly, self-care agency is the individual’s ability to practice self-care (Kumar, 
2007). If, after gaining the knowledge, the patients are not able to take care of their daily 
lives, then it would show negatively on the care-giver (Kumar, 2007). The patients should 
be able to perform the function gained by the knowledge through the program and make 
better decisions regarding their care. 
Third, therapeutic self-care demand is the set of self-care activities needed to meet 
self-care needs (Kumar, 2007). This would include follow-up with providers to prevent 
further problems.There are certain demands that patients are expected to meet during 
their lifetime (e.g. maintaining integrity structure and function – be aware of the various 
changes in the life cycle, follow-up with medical care). The demand for therapeutic self-
care in regard to health deficit refers to those health changes that bring about needs for 
action to prevent further problems (Kumar, 2007).  
Fourth, self-care deficit is the gap between self-care agency and self-care demand 
(Kumar, 2007). This represents the difference between what the individual can do and 
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what is needed. Many of the patients verbalized that they may not be able to meet their 
demand due to noncompliance and poor self-care, and so will need an assistant.  
The fifth concept is nursing agency, which is the nurse’s ability to meet the 
demands of others (Kumar, 2007). Here, the DNP graduate will be able to share the 
experience gained through the development and initiation of the program with the 
patients. This will increase the power of these patients to engage in self-care.  
Lastly, the sixth concept associated with Orem’s theory is the nursing system, 
which is the package of nursing responsibilities, roles, relationships, and actions that is 
organized to meet the client’s demand (Kumar, 2007). This concept is similar to the clinic 
environment in which patients are treated and follow-up care is given (Zaccagnini& 
White, 2011). The patients in the mental health clinic will have access to a supportive 
educative nursing system, where the DNP graduate provides information about 
depression, diabetes, quality ofcareand self-management to enhance self-care 
(Kumar,2007).  
Orem believed that nursing is a practical science with both theoretical and 
practical knowledge. She taught that nursing is different from other disciplines and 
services because of its focus on human beings and the human experience (Zaccagnini& 
White, 2011).Orem’s theory is relevant for guiding practice in any care setting or 
specialty area and can be used to organize care for the identified population of the dual 
diagnosed patients, based on their self-care deficit and their readiness to learn. According 
to Terry (2012), readiness to learn and motivation are directly linked to the need to know, 
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andadult learners must identify a gap in their learning and need to know, placing value on 
the information presented for the learning to be effective. Using Orem’s nursing theory, 
concepts can be integrated with middle range theories pertaining to health promotion and 
family systems to guide health assessment, selection of appropriate health outcomes, and 
carrying out nursing intervention. 
According to Comley (1994), Orem views humans as bio-psychosocial beings, 
capable of and willing to provide care for themselves. This self-care behavior is a learned 
behavior directed at meeting needs that is continuous throughout adult life. This relates to 
this DNP project because the aims of patient education extend beyond dissemination of 
information (Wilson, Mood, Risk, & Kershaw, 2003). The overall intent is to provide 
patients with information and instructions that will enable them to achieve an optimal 
level of health and prevent risk (Wilson et al., 2003). 
Summary 
Living with diabetes is known to impact the individuals’ health related QOL and 
may be associated with an increased risk of developing depression (Rasekaba et al., 
2012). Depression leads to poorer outcomes and increased risk of complications due to 
peripheral glucose deregulation and lower adherence to glucose monitoring, exercise, diet 
and medical management (Lee et al., 2009). The relationship between poorer QOLand 
greater depression is stronger in patients with poorer glycemic control than those with 
better glycemic control (Lee et al., 2009).Renn, Feliciano and Segal (2011) reported that 
one line of research seeks to demonstrate that depression is a consequence of diabetes, 
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and that people with diabetes are more likely to develop depression than those without 
diabetes. Renn et al. (2011) stated that despite the promising yet somewhat contradictory 
theories, the exact nature of the relationship, and the direction of the relationship remain 
unknownTankova et al.(2004) stated that patient education is considered the most 
noticeable innovation in patient care, and that education of patients helps dramatically, 
but its efficacy varies to great extent according to which aspect of the disease has to be 
controlled and to the behavioral changes needed. 
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Section 3: Approach 
Introduction 
The primary purpose of this program was to determine whether compliance 
medication education can improve the QOL in older adults diagnosed with diabetes and 
depression. The aim of this program was to evaluate the impact that a 4-week, one day 
per week education program on diabetes and depression have on the QOL of these older 
adults following their participation in the program. This section outlines the approach 
used in this project.  
Project Design/Methods 
The design for this project was a quality improvement program based on using a 
QOL and demographic questionnaire to gather data from patients diagnosed with 
depression and diabetes. This was a prospective pre-post intervention quality 
improvement project. The QOL questionnaire was used before and after the educational 
program to compare the difference in percentage change. According to Dimitrov and 
Rumrill (2003), the measurement of change provides a vehicle for assessing the impact of 
services, as well as the effects of specific counseling and allied health intervention. 
Participants were asked to complete a QOLquestionnaire (Appendix B), which took 
approximately 10minutes to complete.TheQOLquestionnaire  consistedof 26questions 
asking about participants’ physical health, psychological issues, social relationships, and 
their environment. 
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Population and Sampling 
This project used a convenience sample from an outpatient mental health clinic in 
a suburban area in thenortheasternregion of the United States. Convenience sampling was 
inexpensive, accessible, and provided a means to acquire information in explored areas 
(Burns & Grove, 2011). This method of sampling was selected because the participants 
shared the same common diagnosis. The population for this projectincluded male and 
femalepatients between the ages of 50 to 89 admitted at the facility and diagnosed with 
diabetes and depression. The patient population at the facility was mixed and varied in 
age. Burns and Grove (2011) considered convenience sampling a weak approach because 
it provides little opportunity to control bias. Mygoalsin sampling wereto obtain a 
representative sample; this means that the sample wassimilar to the population from 
which it was drawn in all areas except that it contained fewer people than the population 
(Terry, 2012). The sample size for this program was 28 participants.  
DataCollection 
For the protection of the human subjects, approval fromWalden University 
Institutional Review Board (IRB) was sought. According to Terry, (2012) this signified 
participant fulfillments, minimized risk, equitable selection, data monitoring, and 
provisions to ensure confidentiality and privacy. Before any program-related procedures 
were instituted, permission was obtained from Walden University IRB (No 07-22-15-
0317569). The clinic coordinator was notified of the commencement date for the 
program. Of the participants that were referred by the clinicians of the facility, 50 were 
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contacted via telephone for the initial program meeting. The total attendance of 
participants in the program was 28. There was no consenting for this program, the 
attendance of these patients to the program indicated that they had consented to 
participate in the program. The participants signed the attendance sheet at the beginning 
of each program. The demographic questionnaire (Appendix A)was completed, which 
consisted of seven items: gender, age, educational level, marital status, race, language, 
and type of diabetes.  
A compliance questionnaire (Appendix C) was also completed by participants. 
This included questions on participants’ symptoms, diet, physical activities, medication 
regimen, and medical care. The compliance questionnaire information was important in 
terms of establishing the knowledge, compliance, and the degree of functioning of 
participants.  The success of this education program was dependent on the willingness of 
these participants to carry out activities that would improve their QOL. Using the QOL 
instrument (Appendix B), each applicant indicated their responses to perceptions of their 
QOL on a 5-point Likert scale ranging from 1=very poor or not at all to 5=very good or 
very satisfied.  
After completion of the educational program, at the end of the 4th week, 28 
participants took the QOL questionnaire (posttest)at the clinic immediately following the 
program. The data were collected and kept by meat the clinic and will be kept for a 
period of 7 years. I input data collected into a secure, password protected computer for 
my analysis. All demographic and QOL information obtained were protected by placing 
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the data in a secure paper generated file that was be locked in a secure drawer in my 
office. Each QOL questionnaire was identified by a three-digit code (e.g.,Bxx). The first 
digit indicated the questionnaire used and the subsequent two digits indicated the number 
of participant who completed the program. Data were permanently removed from the 
computer following analysis completion. This file will be kept for a period of 7 years, as 
is the policy of the organization and the Walden University IRB. 
Timeline 
Task A: Upon approval from the IRB, I notified the clinic coordinator of the 
commencement date of the program, and the participants were also contacted.  
Task B: The QOL Demographic and Compliance questionnaires were given to 
participants and were completed.  
Task C: I collected the demographic data, medications compliance form, and 
the pretest QOL data. Pretest QOL data were input into my secure, password 
protected computer, were analyzed, and then stored in a locked filing cabinet.  
Task D: The 60-minute long,4-week educational program was implemented 
at the clinic. The educational program was conducted in a group format and 
the participants took part in the discussion. The physiology of both diabetes 
and depression were discussed, including discussion on specific symptoms 
and medications and side effects.  
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Task E: At the end of the 4-week program, on the last day of the teaching 
session, the participants were given the post QOL questionnaire, which they 
returned to me before leaving the clinic.  
According to Terry (2012), provisions to ensure participants’ confidentiality and 
privacy will be maintained by simply using a code to identify each participant.The 
postsurvey data were entered into the secure, password protected computer for analysis. 
Paper copies of the surveys will be stored in a locked filing cabinet designated for this 
project for 7 years. After completion of the analysis, the data were permanently removed 
from the computer  
Instruments 
World Health Organization’s Quality of Life Questionnaire (WHOQOL-
BREF).This tool measuredthe QOL of the participants in the study. Data were collected 
using thisscreening tool at the initial visit (preeducation data). It was also used at the end 
of the educational program (post education data). This tool was usedbecause it measured 
the participants’ QOL, was a reliable and validated tool, and the results can be 
generalized to other situations. 
The WOQOL-BREFwaschosen as a QOLmeasurement because it has been used 
already in studies on several medical conditions such as rheumatoid arthritis, back pain, 
also in depression, and has successfully detected changes after effective treatment of pain 
conditions (Aigneret al., 2006). According to Dimitrov and Rumrill (2003), internal 
validity is the degree to which the experimental treatment (i.e., education) makes a 
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difference in the specific experimental settings. External validity is the degree to which 
the treatment effect can be generalized across populations (Dimitrov&Rumrill, 2003). In 
this study, the pretest and posttest controlled the participants’ knowledge, health, etc., and 
this could contribute to the program’s validity. The tool used in this program measured 
the participants’ QOL, and the results of this program can be generalized to other 
situations. Test criteria were found to be good to excellent, justifying the use of this 
instrument with a range of patients with chronic and acute illness (Aigner et al., 
2006).Reliability, validity, test-retest and sensitivity to change analyses show that the 
WHOQOL-BREF performs according to international standards (Aigner et al., 2006). 
The patients indicated on a Likert scale of 0 to 5 the degree to which they have 
been bothered by symptoms/issues during the past month. A low score indicated poor 
QOL, while a higher score indicated better QOL (Aigne et al, 2006).The Likert scale is 
the most commonly used psychometric scale among psychological measurements that 
require self-reporting (Wakita, Ueshima, & Noguchi, 2012). According to Burckhardt 
and Anderson (2003), the QOL is scored by adding up the score on each item to yield a 
total scorefor the instrument. Scores can range from 16 to 112. The average total score 
for healthy populations was about 90 (Burckhardt &Anderson, 2003). I received 
permission (Appendix G) from the WHOQOL-BREFto use the survey for this evaluation. 
Demographic Questionnaire. The information obtained from this questionnaire 
(Appendix A) included the self-report of participant’s gender, age, educational level, 
marital status, cultural background, language, and type of diabetes. These data 
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werecollected to describe the sample across demographic characteristics, and the 
variables were expressed as range, frequency, means, and percentages. Results are 
presented in Section 4.  
Compliance Questionnaire.The information on this questionnaire (Appendix C) 
was collected only at the initial visit. It included the participants’ report of their 
symptoms of diabetes and depression, medical condition and treatment, diet, medications, 
and physical activities. The compliance report was used by me to obtain information 
about each participant’s knowledge of specific self-care behaviors. It simply asked about 
their symptom management, dietary and medication regime, and their physical and 
medical routine. The compliance questionnaire was a self-developed tool, that was based 
on a” no” or “yes” answer, and is scored on a scale that ranges from 1 to 28 (Scale: 
Selections 1 to 10 = 1 point each, Selection 11 = 1 to 3 points, Selection 12 = 1 to 4 
points, Selection 13 = 1 to 4 points, and Selection 14 = 1 to 7 points). 
Protection of Human Subjects 
The demographic information did not contain any patient identifiers, and the data 
were entered in a secured, password protected computer. The copies of the paper data 
were stored in a locked filing cabinet at the clinic with access only by me. I will not 
remove any paperwork from the organization that may contain patient identifiers and did 
not use any patient identifiers in the program evaluation. 
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Intervention 
Creating compelling and effective health programs is an important, though often 
challenging role. A health program may be defined as any educational activity designed 
to inform and teach about health-related topics with the goal of affecting behavior 
(Wyatt, Krauskopt, & Davidson, 2008). The focus of this program was medication 
compliance. Compliance, as defined by Cohen, Christensen, and Feldman (2012), is the 
extent to which patients take medications as prescribed by a health provider and in 
accordance with instructions. Medication compliance is a significant problem that 
primarily affects patients with chronic diseases (Cohen et al., 2012). Noncompliance is 
harmful to the health care system, from a clinical as well as an economic standpoint. 
Barriers to adherence include out-of-pocket costs for pharmaceuticals, side effects, 
difficulty of managing multiple prescriptions, and patients’ understanding of disease and 
ability to navigate the health care system (Cohen et al., 2012). 
According to Darden (2014), adults have intrinsic motivation that relates to real 
life, they are goal oriented, and the information given must be purposeful and practical. 
The aim of patient education is to make the patient more knowledgeable about their 
disease, build a more positive attitude, and make the person an active partner in therapy 
(Thakudesai, Kole,&Pareek, 2004).In my education program, the physiology of both 
diabetes and depression were explored, including specific medications and their side 
effects. This was 90 minutes in total for the first and fourth weeks, and 70 minutes for the 
second and third weeks.  The weekly sessions consisted of group discussion and 
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information included diabetic and depression handout and booklets. Video tapes with 
information on nutrition, self-monitoring of blood sugars, and taking medications 
appropriately were viewed by the participants followed by open discussions. Adults learn 
differently and have different motivations. The educational program covered all the major 
aspects of diabetes and depression and the effects on QOL. The self-management goals of 
this program were to improve psychosocial skills—to address attitudes, beliefs, and 
behaviors to chronic disease; and to improve QOL. For this program, the evidence for 
practice on both DM and depression were obtained from the American Diabetes 
Association May/June 2015 magazine, and Diabetes A to Z, revised edition published by 
the American Diabetes Association, best practice seminars, information received from the 
AANP conference, June of 2014, pharmaceutical research videos on understanding 
depression, and a guide to weight management.  
Program Evaluation 
The evaluation model that was aligned with this program was impact evaluation. 
According to Kettner, Moroney, and Martin (2013), impact evaluation differs from other 
types of evaluation in that the focus is on changes in program participants and not 
changes in organizations and communities. Impact evaluation is aimed at providing 
feedback to help improve the design or programs and policies (Kettner et al., 2013). In 
addition to providing for improved accountability, impact evaluations are a tool for 
dynamic learning, allowing policymakers to improve ongoing programs and ultimately to 
better allocate funds across programs (World Bank, 2013). As a component of the 
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monitoring and evaluation process, impact evaluations are an essential instrument to test 
the validity of specific approaches (Hodges &Videto, 2011). Hodges and Videto (2011) 
stated that impact evaluation is the measurement of the event to which the program has 
caused the intended short-term changes in the target population. The QOL questionnaire, 
the impact evaluation tool was used at the initial visit with each participant to assess their 
overall  QOL baseline, and at the end of the education program to evaluate the outcome. 
At the end of the program, the change in patients’ perceived  QOL from pre to post 
educational program participation was measured through the difference in survey 
response scaled scores in terms of a percent change. The responses were analyzed using a 
spread sheet and bar graphs to assess the effectiveness of the program at improving the 
QOL of these participants by comparing the pre and post program data in terms of 
percent change. Demographic data were analyzed and presented using frequencies, 
percentages, and mean values where appropriate to describe the sample.  
 The aims of patient education extend beyond dissemination of information. The 
overall intent was to provide patients with information and instructions that will enable 
them to achieve an optimal level of health and prevent risk (Wilson et al., 2003). 
Consistent and aligned with the aims of patient education is the presentation of an 
evaluation model that can guide practitioners in determining whether the materials used 
are congruent with the therapeutic self-care and self-care abilities of the patient (Wilson 
et al., 2003). 
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Summary 
Two common disorders, depression and diabetes, are complex diseases with 
manifold genetic and environmental contributors to pathogenesis. There is clearly an 
increased prevalence of depression among diabetic patients (Rustadet al., 2011). The 
design for this project was a quality improvement program based on using a QOL and 
demographic questionnaires to gather data from patients diagnosed with depression and 
diabetes. This was a prospective pre-post intervention quality improvement project. The 
measurement of change provides a vehicle for assessing the impact of rehabilitation 
services, as well as the effects of specific counseling and allied health interventions 
(Dimitrov&Rumrill, 2003).The success of this medication education program was 
dependent on the willingness of these participants to carry out activities that will improve 
their QOL. In this DNP project, the evaluation determined if a 4-weekmedication 
education program provided toa sample of adult patients diagnosed with diabetes and 
depression has a positive effect on their QOL. 
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Section 4: Findings, Discussions,& Implications 
Introduction 
The purpose of this quality improvement project was to assess and evaluate 
whether medication compliance education improved theQOL in older adults diagnosed 
with diabetes and depression. The WHOQOL-BREF questionnaire was used pre- and 
post implementation to assess whether the medication compliance education program 
improve the QOL of the participants.  The objective of this program was to enable 
participants to assume a primary role in managing their diagnosis including monitoring 
their symptoms and adherence to their medication regimen. The goal was to evaluate 
whether medication compliance education can improve QOL as measured by the QOL 
questionnaire. Therefore, the question for this program evaluation concerned the use of 
medication compliance education to improve QOL. In this compliance education 
program, all 28 participants were diagnosed with diabetes and depression. The QOL 
questionnaire also measured the program’s effectiveness in improving QOL of the 
participants and results revealed measurable improvement in all three categories 
including physical health (28.5%), social relationship (32.3%), and environment (25%). 
Summary of Findings 
Demographic Data 
The demographic questionnaire (Appendix A), was completed by all28 
participants and then collected by me. This consisted of seven items, included gender, 
age, educational level, marital status, race, language, and type of diabetes. The population 
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of this program consisted of 79% females and 21% males. The mean age of the 
participants was 65.5, the median age was 64.5, and the ages ranged from 52 to 84. The 
ethnic composition of the sample was African American/Black 29%, Caucasian 21%, 
Hispanic 36%, and other 14%. Seventy- five percent of the participants had some form of 
high school and/or college education (see Table 1). 
Table 1 
Demographic Data 
Characteristics 
 
Number of 
Participants 
Percentage 
Gender 
               Female 
                Male 
 
22 
6 
 
79% 
21% 
Age 
                  50-59 
                  60-69 
                  70-79 
                  80-89 
 
8 
12 
6 
2 
 
29% 
43% 
21% 
7% 
Ethnicity 
                  African 
American/Black 
                  Caucasian/White 
                  Hispanic 
 
8 
6 
10 
4 
 
29% 
21% 
36% 
14% 
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                  Other 
Education 
                  None 
                  High School 
                  College 
 
7 
12 
9 
 
25% 
43% 
32% 
Language 
                  English 
                  Spanish 
 
22 
6 
 
79% 
21% 
Marital Status 
                   Single 
                   Married 
                   Divorce 
                   Widow 
 
9 
11 
3 
5 
 
32% 
39% 
11% 
18% 
Diabetes Type 
                    Type 1 
                     Type 2 
 
5 
23 
 
18% 
82% 
Depression 
 
28 100% 
Note: N= 28 
Compliance Questionnaire 
A compliance questionnaire (Appendix C) was also completed by all participants 
at the initial meeting to assess each participant’s behavior in terms of taking medications, 
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being aware of symptoms, following a proper diet, being physically active, and following 
up with medical care. Through this educational program the participants were taught 
proper management of medication and diet and how to incorporate some form of physical 
activities in their daily routine.  
Table 2  
Compliance Data 
Characteristics Frequency Percentage 
Awareness of symptoms 
          Non-compliant 
          Compliant 
 
21 
7 
 
75% 
25% 
Diet 
           Non-compliant 
            Compliant 
 
18 
10 
 
64.3% 
35.7% 
Medication 
             Non-compliant 
             Compliant 
 
12 
16 
 
42.9% 
52.1% 
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Medical Follow-up 
              Non-compliant 
               Compliant 
 
15 
13 
 
53.6% 
46.4% 
Motivation/Physical activity 
                Non-compliant 
                 Compliant 
 
19 
9 
 
67.9% 
32.1% 
Note: N = 28 
A compliance score was calculated for each participant and was then converted 
into a total percentage score (see Table 2). The outcomes were categorized as 
noncompliant (<50%)or compliant (>50%). The best compliance score was for 
medication management (52.1%). More than 50% believed that lack of motivation and 
not being able to afford the more nutritious foods was the reason for the high 
noncompliant rate in diet (64.3%). Two areas that showed poor compliances were being 
aware of the symptoms of the diagnosis (75%)and physical activity (67.9%). Some 
participants believed that lack of knowledge in preparing specific meals was the main 
reason of the noncompliance, and that unhealthy foods were cheaper for them to 
purchase. 
Quality of Life Questionnaire Findings 
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 The QOL instrument developed by the  WHO was used at the initial visit with 
each participant. The 28 participants completed the QOL questionnaire, which were then 
collected by me. The QOL measures reflect a personal sense of physical and mental 
health and the capacity to react to diverse factors in the environment (Drewnowski 
&Evans, 2001). QOL addresses physical state, social functioning, and emotional well-
being. According to Aigner et al.(2006), there are 26 items in four domains (physical 
health, psychological health, social relationships, and the environment) and they are rated 
on a 5-point Likert scale, with a higher score indicating a better QOL. Burckhardt and 
Anderson (2003) stated that the QOL is scored by adding up the score on each item to 
yield a total score for the instrument. The score ranges from 16 to 112, with an average 
score for a healthy population being about 90 (Burckhardt & Anderson, 2003). The WHO 
instrument produces a profile with four domain scores and two individually scored items 
dealing with individual’s overall perception of QOL and health (Appendix E). According 
to the WHOQOL-BREF, the four domain scores are scaled in a positive direction with 
higher scores indicating a higher QOL. 
 The score for this project ranged from 26 to 112, with a mean score of 95. The 
first two items dealt with overall health. All 26 items were given a score on a 5-point 
Likert scale: 1= strongly disagree, 2= disagree, 3= neutral, 4 = agree, and 5= strongly 
agree. Each participant answered the question on the QOL questionnaire, the total point 
value for each was taken based on the answers and a numerical point value represents the 
pretest. 
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Table 3 
Pre implementation Data 
Characteristics n Percentage 
General health 11 39.2% 
Physical health 12 42% 
Psychological health 11 39.2% 
Social relationships 9 32% 
Environment 10 35.7% 
Note: The numbers indicate the participants who agree that compliance education does improve 
QOL.N = 28. 
At the end of the program, after the 4th week, another QOL questionnaire was 
completed by the 28 participants, and again the total point value was repeated for the post 
test. A comparison was then made between both the pre- and posttest results. At the end 
of the program, the change in patients’ perceived QOL, from pre- to post education was 
measured through the difference in survey response scale scored in terms of percentage 
change.  
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Table 4 
Post Implementation Data 
Characteristics n Percentage 
General health 12 42.8% 
Physical health 16 57.1% 
Psychological health 19 67.8% 
Social relationships 18 64.3% 
Environment 17 60.7% 
Note: The numbers indicate the participants who agreed that compliance education does improve 
QOL.N = 28. 
 These results indicated that the use of compliance education had a beneficial 
effect on patient well-being.  Educating and supporting patients in managing their daily 
life with chronic disease like depression and diabetes is an important goal of therapy. The 
aim of this education program was to make the participants more knowledgeable about 
depression and diabetes, help build a positive attitude, and increase interest in daily care. 
Table 5 
Comparison of Pre- and Post-implementation Data 
Characteristics Pre- Percentage Post- Percentage Percentage 
Difference 
General health 39.2% 42.8% +3.6% 
Physical health 42% 57.1% +15.1% 
Psychological 39.2% 67.8%% +28.5% 
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health 
Social relationships 32% 64.3% +32.3% 
Environment 35.7 60.7% +25% 
Note: The numbers indicate the participants who agreed that compliance education does improve 
QOL. N = 28. 
Summary and Evaluation of Findings 
 Patients develop complications as a result of poor understanding of the disease 
and inadequate glycemic control. According to Tankova et al. (2004), patient education is 
accepted as an integral part of chronic disease management. In the Healthy People 2000 
report, the chief goal of health promotion was to increase the span of healthy life. In the 
Healthy People 2010 report, the emphasis was helping people to increase life expectancy 
and to improve their QOL. The objective of this program was to determine whether 
medication compliance education can improve patients’ QOL. The findings showed that 
this program had a positive effect on this sample population.  There were compelling 
improvements in physical health (+28.5%), social relationships (+32.3%), and 
environment (+25%). Measurable improvements were also seen in physical health 
(+15.1%) and in general health (+3.6%). The medication compliance was (57.1%). These 
results suggest the effectiveness of this intervention as poor compliance was seen in 
participants not being aware of symptoms (75%), having a poor diet (64.3%), and 
decreased motivation/physical activity (67.9%). 
 The 28 participants in this program were diagnosed with both depression and 
diabetes. The dual diagnosis of depression and diabetes can cause significant 
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deterioration in patients’ QOL. From the participants’ perspective, the education program 
consisted of an overwhelming amount of information, which was usually presented in 
one session. Although they were able to have this program for 4 weeks, they verbalized 
the need for the program to be a continuous process. Patients’ lack of compliance to their 
medication regimen is based on the notion that patients perceive their role in their care as 
passive. After the 4 weeks of the education program, there were overall improvements in 
the level of adherence and an improvement in participants’ QOL. Compliance data were 
not collected at the end of the program, which would have been beneficial to compare the 
difference in pre- and post-implementation.  
Discussions of Findings in the context of the Literature 
 According to Mahmound (2012), the level of compliance varies from patient to 
patient, and other factors can affect compliance, including behavioral change, the 
complexity of the regimen, and how easy the patient can incorporate the change into his 
or her daily routine. The literature on compliance is dominated by reports of patient 
noncompliance with prevention and treatment recommendations, and there are fewer 
reports on how behavior of health care professionals and the delivery of medical care 
contribute to patient compliance (Mahmound, 2012).The results of this program support 
the conclusion of Tankova et al. (2004) that structured patient education improves QOL 
of diabetic patients, reducing their depression and increasing their positive well-being. 
According to Chen et al. (2013), diabetes education is an important aspect in diabetic 
care. Although patents can get information through the Internet, professional classes are 
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still irreplaceable (Chen et al., 2013). Egede and Hernandez-Tejade (2013) believed that 
there is a need to study the mechanisms by which depression and diabetes affects health 
outcome and QOL in order to have a better treatment of diabetes. Given the demographic 
shift in this country, there is a need to perform more studies in minority populations such 
as Hispanicsand African-Americans, who are both overrepresented (Egede& Hernandez-
Tejade, 2013). 
Implications 
 The aging of the population and the increasing prevalence of chronic diseases 
pose challenges to the development and applications of clinical practice guidelines (Boyd 
et al., 2005). Clinical practice guidelines help to define standards of care and focus efforts 
to improve quality (Boyd et al., 2005). The review of the literature revealed a high rate of 
comorbidity of depression and diabetes, and requires the attention of clinicians to screen 
for depression among patient with diabetes. Epidemiologic studies have shown that 
depression in patients with diabetes is associated with poor self-care, including lack of 
adherence to diet, exercise, smoking cessation and disease control medications (Katon et 
al., 2006). This poor adherence associated with depression could lead to increased 
complications of diabetes and raise medical costs (Katon et al., 2006). 
Implications for Practice 
 The results of this program suggest that providing information about medication 
can lower medication noncompliance. The results have clear clinical implications for 
diabetes educators working with patients who have comorbid depression. Many of the 
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participants of the program verbalized seeing improvement in their mood after being 
more compliant with the medications. Because of the tremendous impact of depression 
on diabetes outcomes and the significant burden that these conditions place on medical 
care, strategies need to be implemented by primary care providers. McKeller, Humphreys 
and Piette (2004) stated that not only is depression management meaningful from the 
perspective of a patients’ QOL, but it also appears to have implications for patient’s 
ability to attain diabetes self-care goals This medication education program supports 
successful care and meeting the needs of patients, increasing patient knowledge, 
encourage patient participation, and helping patient to be more in control of their 
healthcare. The findings of the study can make a contribution to daily practice, in any 
primary care setting, to treat older adults with diabetes and depression and being attentive 
to their QOL. 
Implications for Social Change 
 Many reliable but brief screening tests for depression are available, and diabetes 
educators should consider regular screening for depressive symptoms among their 
patients (McKellar, Humphreys &Piette, 2004). The case for vigorous screening to 
identify depression in patients with diabetes is made even more compelling by the fact 
that effective psychotherapeutic and pharmacological treatments exist and may improve 
patients’ glycemic control (McKellar, Humphreys &Piette, 2004). A growing number of 
people are searching to understand the meaning of empowerment and ways it can be used 
to change their lives (Lord &Hutchison, 1993). Lord and Hutchison (1993) stated that 
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empowerment is understood as a process for people to take power, and in order to do so 
they need to gain information about themselves and their environment and be willing to 
identify and work with others for change. 
Implications for Future Research 
 Further studies are needed of the mechanism by which depression in diabetics 
affects health outcome and QOL in order to improve diabetes treatment effectiveness 
(Egede& Hernandez-Tejada, 2013). Another area of research may involve investigating 
the effects of positive emotional characteristics on patient outcomes (Egede& Hernandez-
Tejada, 2013). The focus on glycemic control and complications is already a routine 
aspect of diabetes care, improvement in mental health care can go a long way towards 
increasing diabetic specific QOL in this population. Mental health issues need to be 
addressed as they were an important contributor to decreased diabetic QOL. In the future 
QOL will continue to be the center of our values, and also covers a person’s individual 
position in relation to the culture and value system in which they live. 
Project Strengths and Limitations 
Strengths 
 The program evaluation used data collected over a 4 week period of time. The 
data were examined the day prior to implication of the program, and again after the 
implementation of the program. The strengths of the project included the use of the QOL 
questionnaire, which highlighted specific areas of improvement that was most affected by 
the implementation of the compliance program. The support of the organization’s leaders 
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during the entire process offered great strength. The tool used for this project also 
provided strong support. The WHOQOL-BREF has several strengths as it is based on a 
cross-culturally sensitive concept and is appropriate for use in multi-national 
collaborative research. (Skevington, Lotfy, &O’Connell, 2004).Skevington, Lotfy, and 
O’Connell (2004) stated that the instrument consists of QOLitems that are concerned 
with the meaning of different aspect of life. 
Limitations 
 The major limitation of this project was that the population was small sample size 
from a single clinic, and therefore, limits generalizability to other groups. A second 
limitation was the absence of a control group, which limits internal validity of the 
outcome. Thirdly, the cultural and language differences may have introduced unintended 
variables. Despite the limitations, the study provided valuable information on the role of 
education on various aspects in the management and care of chronic disease. 
Recommendations 
 My recommendations would include increasing the sample size of the participants 
and extending the data collection and implementation time period. Evaluation of the 
effectiveness of programs and their impact on public health is more difficult to establish 
(Adams, 2010). Effective health education would be needed to consider the health 
literacy of individuals. Given the small sample size and the small number of participants 
in the 65 and older age group, further work is needed to establish this with a broader 
sample, and extend the collection of data over a longer period of time. 
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Analysis of Self 
As Scholar 
 The process of developing the DNP project has helped me to feel confident in my 
skills as a researcher and a scholar. Throughout the process of this scholarly journey, I 
have grown as a writer, a researcher, and as an educator. According to the American 
Association of Colleges of Nursing (AACN; 2006), individuals who acquire the DNP 
will seek to fill roles as educator and will use their considerable practice expertise to 
educate the next generation of nurses. A significant change in my development as a nurse 
leader that has occurred, which correlates with Walden’s practice-focused goals, is my 
ability to translate theory and research into evidence-based practice (EBP). In spite of the 
lack of clarity regarding the skills nursing leadership needs to implement and sustain 
EBP, nurse leaders at every level have an obligation to advance change in nursing 
practice by supporting EBP. Successful change leadership involves investing time in 
finding common ground across stakeholders and in building credibility and trust (Chreim, 
Williams, Janz, &Dastmalchian, 2010). As a DNP graduate, I am prepared to develop and 
evaluate care delivery approaches that meet current and future needs of patient 
populations based on scientific findings in nursing and other clinical sciences, as well as 
organizational, political, and economic sciences (AACN, 2006). 
As Practitioner 
 As a DNP graduate I will generate evidence through practice to guide 
improvements in practice and outcome of care (AACN, 2006). I will have autonomy on 
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the assessment and treatment of patients. I have grown through the process of Clinical 
Scholarship and Analytical Methods for Evidence-Based Practice (AACN, 2006). The 
DNP project has provided me with the opportunity to promote continued professional 
development, specifically in developing writing skills in order for dissemination of 
research results in a selected nursing publication. According to the AACN (2006), as a 
doctoral graduate , I will be efficient in the work place in demonstrating advanced level 
of clinical judgment, system thinking, and accountability in designing, delivering, and 
evaluating evidence-base care to improve patient outcomes (AACN, 2006). 
As Project Developer 
 My role as a nursing leader is to develop and sustain therapeutic relationship and 
partnership with patients and other professionals to facilitate optimal care and patient 
outcome (AACN, 2006). The DNP project will serve as a foundation that may open doors 
for future collaboration with other professionals within the healthcare industry. This DNP 
program has prepared me for further development and evaluation in care delivery 
approaches that meet current and future needs of patient populations based on scientific 
findings in nursing and other clinical sciences, as well as organizational, political, and 
economic sciences (AACN, 2006). The DNP project has caused significant growth in 
knowledge during the overall process. 
Summary and Conclusion 
 Diabetes and depression are serious chronic diseases that negatively affect QOL. 
Policies and programs are increasingly focused on identifying ways to improve QOL and 
60 
 
 
health status rather than just extending life. Whatever the mechanism involved, the data 
indicate that the addition of depression to diabetes has a severe impact on quality of life. 
A large number of patients with diabetes experience depressive symptoms. Screening for 
depression is important for patients with diabetes because even low levels of depression 
are associated with poor self-care and medication compliance. The goal of this education 
program was to enable patients to assume a primary role in managing their conditions: 
monitoring symptoms, adjusting medications, and making decisions as to when additional 
medical care is necessary. Treatment of depression may lead to improvement in diabetes 
self-care and compliance and may improve patient outcome. The potential benefits of an 
educational program must be considered in improving QOL in older adults. Psychiatric 
nurse practitioners play an important part in the care and management of these dual 
diagnoses patients and can take the lead in developing educational programs and practice 
protocols for primary care providers focusing on treatment of patients with depression 
and diabetes.  
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Appendix A 
Demographic Questionnaire 
Before we begin I would like to ask you to answer a few general questions about 
yourself. 
1 What is your gender?   Male  Female 
 
2 What is your date of birth?  ____/    _____/   _______ 
      Day      Month       Year 
3 What is the highest education? None at all          Elementary School 
      High School     College 
4 What is your marital status?  Single      Married        Separated     
Divorced 
      Widowed         Other_____________ 
5 Ethnic origin: 
  White  Black  Asian/Pacific  Hispanic 
    Filipino American Indian    Other____________ 
6 What is your common language? English Spanish
 Other_________ 
 
7 Please indicate which type of diabetes you have: 
 Diabetes type 1 Diabetes type 2  
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Appendix B 
Quality of Life Questionnaire ID#_______________ 
 
1 Are you feeling well?   Yes     No 
2 If no, what is the problem?  _______________________________ 
 
Please read each question, assess your feelings, and circle the number that gives the best 
answer for you. 
Very poor  Poor  Neutral Good  Very good 
        1       2         3       4           5 
3 How would you rate your quality of life? 1 2 3 4        5 
4 How well are you able to get around?  1       2         3        4 5 
5 How satisfied are you with your health?   1       2        3 4 5 
6 How satisfied are your with your sleep?   1       2        3 4 5 
7 How satisfied are you with your ability to    1      2        3 4 5 
perform your daily living activities? 
8 How satisfied are you with your abilities?     1  2      3 4 5 
9 How satisfied are you with your personal     1  2      3 4 5 
 relationships? 
10 How satisfied are you with your sex life?     1   2     3 4 5 
11 How satisfied are you with the support      1    2    3 4 5 
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 you get from friends? 
12 How satisfied are you with the conditions  1 2 3      4         5 
 of your living place? 
13 How satisfied are you with your access to  1    2  3     4         5 
 health services? 
14 How satisfied are you with your mode of         1  2   3     4        5 
 transportation? 
Not at all A  little Moderate amount Very much  An extreme 
amount 
          1            2                 3     4   5 
15 To what extent do you feel that physical           1 2           3         4       5 
 pain prevents you from doing things? 
16 How much do you enjoy life?   12           3          4       5 
17 How safe do feel in your daily life?         12           3        4    5 
18 To what extent do you feel your life to         1 2           3         4      5 be 
meaningful?   
19 How well are you able to concentrate?  1 2           3        4      5 
20 How healthy is your physical environment?           1    2          3        4     5 
21 Do you have enough energy for everyday life? 1  2          3        4     5 
22 Are you able to accept your bodily appearance? 1      2          3       4      5 
23 Have you enough money to meet your needs? 1      2          3       4      5 
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24 To what extent do you have the opportunity  1      2          3       4      5 
 for leisure activities? 
25 Symptoms 
 How much time during the past month… 
      Never Rarely Sometime Often Always 
 Were you discouraged  by      
 your  health problems?...............      1   2        3         4  5 
 Were you fearful of your 
 future health?...........................        1     2           3          4              5 
 Was your health a worry 
 in your life?................................          1     2         3            4              5 
26 Daily activities 
 Has your health interfered with 
 Normal social activities?.............            1  2  3 4 5  
 Has your health interfered with 
 Household chores/shopping?...... 1         2            3   4        5 
 Has your health interfered with 
 your hobbies?............................... 1          2            3    4         5 
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Appendix C 
Compliance Questionnaire 
In the past week, did you have any of the following symptoms…. 
1 Increased thirst?         No             Yes  
2 Decreased appetite?    No  Yes  
3 Nausea or vomiting?          No              Yes  
4           Times when you feel faint /passed out?              No                           Yes 
5 Lightheaded?                     No               Yes         
  
6 Frequent urination at nights?   No  Yes    
7 Severely high blood sugar?        No  Yes    
8 Night sweats? Sleep disturbance?  No  Yes   
9 Depressed Mood?          No  Yes   
10 Suicidal thoughts?          No  Yes   
            What do you do if these symptoms are present? ………………………  
11 Your diet 
 Did youskip breakfast today?                                No                          Yes 
 Do you have 3 meals daily?                                   No                          Yes 
 Are they balanced meals?            No                          Yes   
12 Physical activities 
 During the past week, did you spend any time on the following? 
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                                                                                                No                               Yes 
 Stretching/exercising  None 15- 30 min   30-60min   1-2hrs>3hrs 
        
 Walking exercise  None 15-30 min     30-60 min    1-2hrs     >3hrs 
 Swimming    None   15-30 min     30-60 min    1-2hrs    >3hrs 
 Aerobic exercise  None    15-30 min     30-60 min    1-2hrs    >3hrs 
13 Are you taking pills for diabetes?                       No                                         Yes 
 Do you take insulin injections?   No                                         Yes 
 Do you take pills for cholesterol?       No                                          Yes 
 Are you taking pills for depression?                   No                         Yes 
14 Medical Care 
 In the past 6 months, have you visit a physician?                                             N/Y 
 In the past 6 months, have been hospitalized?                                                  N/Y 
 In the past 6 months have you been to the ER?                                                 N.Y 
 Have had you had recent eye examined?                                                           N/Y 
 Have had your feet examined by a doctor/nurse?                                              N/Y 
 Do you check your blood glucose daily?                                                            N/Y 
 Did you have your Hemoglobin done for the past 3-6 months?                  N/Y 
Scale:  No. 1-10 = 1 point each. No. 11 = 1-3 pointsNo. 12 = 1-4 points. No 13= 1-4 
points. No. 14= 1-7 points   
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Appendix D 
Education Program Guidelines (Weeks 1 to 4) 
Topic: Diabetes and Depression, Treatment/Compliance and Quality-of-life 
Objective:  To determine whether education on medication compliance and 
treatment can improve quality-of-life in older adults diagnosed with diabetes and 
depression 
Table of Content: 
Physiology of diabetes and depression 
Types of diabetes:  Type 1, Type II 
Treatment - pills or insulin –monitoringof daily blood sugars, and quarterly 
Hemoglobin A1c check 
Taking care of your diabetes – hypoglycemia, medication, nutrition, exercise, 
medical appointments and medical follow-ups, foot care 
Depression:  
Depressive symptoms – for example; depressive feelings, sadness, worry, 
hopelessness, suicidal thoughts    
Treatment - psychotherapy and/or antidepressant 
Common link between diabetes and depression 
Quality of life – physical, functional, social and emotional well-being 
Effects of diabetes and depression on quality-of-life 
Complications - include cardiovascular, hypertension, neuropathy, vascular, 
kidney 
Group interaction - feedback 
Conclusion 
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Appendix E 
WHOQOL-BREF 
Domains and Questions Raw Domain 
Score 
Raw Item 
Scores 
Overall Quality of Life and General Health 
How would you rate your quality of life? 
How satisfied are you with your health? 
(2-10) 
 
 
(1-5) 
(1-5) 
Domain 1  Physical Health 
To what extent do you feel that physical pain prevent 
you from doing what you need to do? 
How much do you need any medical treatment to 
function in your daily life? 
Do you have enough energy for everyday life? 
How well are you able to get around? 
How satisfied are you with your sleep? 
How satisfied are you with your ability to perform your 
daily living activities? 
How satisfied are you with your capacity to work? 
(7-35) 
 
 
 
(1-5) 
 
(1-5) 
 
(1-5) 
(1-5) 
(1-5) 
(1-5) 
 
(1-5) 
Domain  2  Psychological Health 
How much do you enjoy life? 
To what extent do you feel your life to be meaningful? 
How well are you able to concentrate? 
Are you able to accept your bodily appearance? 
How satisfied are you with yourself? 
How often do you have negative feelings such as blue 
mood, despair, anxiety, depression? 
(6-30)  
(1-5) 
(1-5) 
(1-5) 
(1-5) 
(1-5) 
(1-5) 
Domain   3  Social relationships 
How satisfied are you with personal relationships? 
How satisfied are you with your sex life? 
How satisfied are with the support you get from your 
friends? 
(3-15)  
(1-5) 
(1-5) 
(1-5) 
Domain  4  Environment 
How safe do you feel in your daily life? 
How healthy is your physical environment? 
Have you enough money to meet your needs? 
How available to you is the information that you need in 
your daily-to-day life? 
To what extent do have the opportunity for leisure 
activities? 
How satisfied are you with the condition of your living 
• (8-40) •  
• (1-5) 
• (1-5) 
• (1-5) 
• (1-5) 
 
• (1-5) 
• (1-5) 
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place 
How satisfied are you with your health services? 
How satisfied are you with your transport? 
• (1-5) 
• (1-5) 
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Appendix F 
Data 
ID # Age Language Race Sex Education Diabetes 
Ty. 1 or 
2 
Marital 
Status 
001Q 64 Spanish Hispanic Female HS 2 Single 
002Q 57 English Caucasian Male HS 2 Widow 
003Q 55 English Hispanic Female HS 2 Married 
004Q 84 English Caucasian Female College 2 Widow 
005Q 75 Spanish Hispanic Female HS 2 Single 
006Q 62 English Hispanic Female College 2 Divorce 
007Q 62 English Other Female College 1 Single 
008Q 65 English  Black Female None 2 Divorce 
009Q 82 Spanish Hispanic Female None 2 Widow 
010Q 74 English Black Female College 2 Single 
011Q 67 English Hispanic Female HS 2 Married 
012Q 60 English Black Male None 1 Married 
013Q 64 English Other Female  HS 2 Single 
014Q 56 English Caucasian Female  HS 2 Married 
015Q 63 Spanish Hispanic Male HS 1 Married 
016Q 76 English Caucasian Male None 2 Married 
017Q 74 English Black Female HS 2 Single 
018Q 53 English Black Female College 2 Single 
019Q 58 English Black Female College 1 Single 
020Q 55 English Other Female College 1 Widow 
021Q 68 English Caucasian  Female College 2 Single 
022Q 72 English Black Female None  2 Married 
023Q 68 English Other Female HS 2 Married 
024Q 66 Spanish Hispanic Male None 2 Married 
025Q 54 English Black Female College 2 Divorce 
026Q 78 Spanish Hispanic Male HS 2 Widow 
027Q 69 English Hispanic Female None 2 Married 
028Q 52 English Caucasian Female HS 2 Married 
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